Exelixis, Inc. (EXEL): Price and Financial Metrics
EXEL Price/Volume Stats
| Current price | $42.37 | 52-week high | $48.85 |
| Prev. close | $42.22 | 52-week low | $21.36 |
| Day low | $42.05 | Volume | 2,139,900 |
| Day high | $42.62 | Avg. volume | 2,867,144 |
| 50-day MA | $38.89 | Dividend yield | N/A |
| 200-day MA | $33.99 | Market Cap | 11.55B |
EXEL Stock Price Chart Interactive Chart >
Exelixis, Inc. (EXEL) Company Bio
Exelixis is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. The company was founded in 1994 and is based in San Francisco, California.
EXEL Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
EXEL Price Returns
| 1-mo | 15.10% |
| 3-mo | 9.82% |
| 6-mo | 18.29% |
| 1-year | 91.03% |
| 3-year | 117.62% |
| 5-year | 89.41% |
| YTD | 27.24% |
| 2024 | 38.81% |
| 2023 | 49.56% |
| 2022 | -12.25% |
| 2021 | -8.92% |
| 2020 | 13.90% |